PCM
ADAP

Pinz Capital Management’s Adaptimmune Therapeutics ADAP Stock Holding History

Pinz Capital Management’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-158,400
Closed -$1.59M – 113
2020
Q2 		$1.59M Buy
+158,400
New +$1.59M 0.73% 63